Priority Date: 11.03.11 (US 201161451848P)

USE OF INHIBITORS OF EGFR-FAMILY RECEPTORS IN THE TREATMENT OF HORMONE REFRACTORY BREAST CANCERS

  • Application ID: EP12711080
  • Status: APPLICATION WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1128.02
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) J A Kemp is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 11.03.2011 - Priority Date (US 201161451848P)
  • 20.09.2012 - Publication A2 (WO2012125573)
  • 15.01.2014 - Publication A2 (EP2683741)

IPC Classification